Paris, France

Laurent Bouvenot

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sanofi. Active years: 2013.


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Laurent Bouvenot

Introduction

Laurent Bouvenot is a notable inventor based in Paris, France. He has made significant contributions to the field of chemistry, particularly in the development of synthetic pathways. His work has led to the creation of a unique method for preparing specific chemical compounds.

Latest Patents

One of Laurent Bouvenot's key patents is titled "Short synthetic pathway for 1,6:2,3-dianhydro-β-D-mannopyranose." This invention relates to a method for preparing 1,6:2,3-dianhydro-β-D-mannopyranose and is characterized by a step of cyclizing the compound B, where R is an activating agent, in the presence of a base selected from among ammonium hydroxides and mineral bases. This patent showcases his innovative approach to chemical synthesis.

Career Highlights

Laurent Bouvenot is currently associated with Sanofi, a leading global healthcare company. His role at Sanofi allows him to apply his expertise in chemistry to develop new solutions in the pharmaceutical industry. His work has been instrumental in advancing the company's research and development efforts.

Collaborations

Laurent has collaborated with esteemed colleagues such as Denis Largeau and Jean-Claude Rovera. These partnerships have fostered a collaborative environment that enhances innovation and drives successful outcomes in their projects.

Conclusion

Laurent Bouvenot's contributions to the field of chemistry and his innovative patent demonstrate his commitment to advancing scientific knowledge. His work at Sanofi and collaborations with other experts highlight the importance of teamwork in driving innovation.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…